CD69 and autoimmune pancreatitis: Instead, TRAV1-2−TRAJ33+ T cells were present in patients with AIP at a comparable level to healthy donors (Figure 1E, red dots) and the frequency of these cells with the high expression level of the activation marker CD69 was significantly higher in patients with AIP than in healthy donors (Figure 1F).